Quinupristin + Dalfopristin

Paul G. Auwaerter, M.D., Paul A. Pham, Pharm.D.

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Patients with serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium(VREF) bacteremia.
  • Complicated skin and skin structure infections caused by Staphylococcus aureus (MSSA) or Streptococcus pyogenes.

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Endocarditis (generally not recommended due to poorer clearance of bacteremia)

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved